Literature DB >> 27461174

Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.

Min-Hyun Park1, So Young Kim2, Eun Yun Roh3, Ho Sun Lee1.   

Abstract

OBJECTIVE: Type 3 secretion system (T3SS) is the most important virulence factor in Pseudomonas aeruginosa infection. Of the various T3SS effector genes, exoS and exoU showed mutually exclusive distributions, and these two genes showed varied virulence. In many pseudomonal infections, the distribution of these genes showed different pattern and it influenced severity of infection. This study was aimed to evaluate differences of virulence factors and antibiotics resistance between chronic otitis media and other body infection caused by P. aeruginosa.
METHODS: To estimate the prevalence of effector genes of T3SS, especially the distributions of exoS and exoU genes and their association with antibiotic resistance in COM, we compared the prevalence of T3SS genes in isolates from COM with those from lower respiratory infection and bacteremia. Other virulence genes, including groEL, pilA, ndvB, lasB, rhlI, and apr, were also studied to evaluate prevalence. These isolates were tested for antibiotic susceptibility, and we examined the association between antibiotic susceptibility and the prevalence of T3SS effector genes.
RESULTS: The COM group showed a significantly higher exoU-positive rate than the control group (70.6% vs. 6.7%; P<0.01). Furthermore, COM patients with exoU showed significant antibiotic resistance to ciprofloxacin and tobramycin (P=0.035), whereas there was no significant difference in the control group.
CONCLUSIONS: The high incidence of exoU-positive P. aeruginosa and ciprofloxacin resistance can explain the chronicity and intractability of infection in COM. Elucidation of this pathogenicity will facilitate the development of new treatment options for COM patients.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotics resistance; Otitis media; Pseudomonas; Type 3 secretion system; Virulence factors; exoU

Mesh:

Substances:

Year:  2016        PMID: 27461174     DOI: 10.1016/j.anl.2016.07.005

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  7 in total

1.  Relationship of biofilm-forming ability of with swimming motility, twitching motility and virulence gene distribution.

Authors:  Jian Shui; Haichen Wang; Xiaoyan Tao; Changhang Min; Jun Li; Mingxiang Zou
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-06-25

2.  In Vitro Investigation of the Antibacterial Activity of Nigella sativa Oil on Some of the Most Commonly Isolated Bacteria in Otitis Media and Externa.

Authors:  Esra Kocoglu; M Tayyar Kalcioglu; Lokman Uzun; Ferhat Zengin; Serdal Celik; Serkan Serifler; Hanife Gulbay; Nevriye Gonullu
Journal:  Eurasian J Med       Date:  2019-10

Review 3.  Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs.

Authors:  Teiji Sawa; Saeko Hamaoka; Mao Kinoshita; Atsushi Kainuma; Yoshifumi Naito; Koichi Akiyama; Hideya Kato
Journal:  Toxins (Basel)       Date:  2016-10-26       Impact factor: 4.546

4.  Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa.

Authors:  Dinesh Subedi; Ajay Kumar Vijay; Gurjeet Singh Kohli; Scott A Rice; Mark Willcox
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

5.  Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study.

Authors:  Brant M Wagener; Naseem Anjum; Sarah C Christiaans; Morgan E Banks; Jordan C Parker; Adam T Threet; Rashidra R Walker; Kayla D Isbell; Stephen A Moser; Troy Stevens; Mikhail F Alexeyev; Jonathon P Audia; Wito Richter; Kierra S Hardy; Lina Abou Saleh; Charity Morgan; Jean-François Pittet
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

Review 6.  Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections.

Authors:  Daniel M Foulkes; Keri McLean; Atikah S Haneef; David G Fernig; Craig Winstanley; Neil Berry; Stephen B Kaye
Journal:  Microorganisms       Date:  2019-12-16

Review 7.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.